Identifying epigenetic-based targets against cancer stem cells in rhabdomyosarcoma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210476
- Recipient
-
University Of Washington UEI HD1WMN6945W6 Part of University Of Washington
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $544,250
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Seattle, WA 98195, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $544,250 Project Grant to the University of Washington under the Military Medical Research and Development program (CFDA 12.420) to identify epigenetic-based targets against cancer stem cells in rhabdomyosarcoma. The three-year award beginning August 1, 2022 will support research to investigate medical solutions for battlefield injuries by exploring innovative biomedical research approaches. Specifically, the University of Washington will conduct applied research to transform military and public health care by developing new targets for treating rhabdomyosarcoma, a type of soft tissue cancer. Insights gained from this research could help the Department of Defense better care for Service Members injured in combat and improve cancer treatment outcomes more broadly.
Quick answers
Who received award W81XWH2210476?
W81XWH2210476 was awarded to University Of Washington by Medical Command (Department of the Army) on August 1, 2022.
How much is award W81XWH2210476 worth?
$544,250 has been obligated on W81XWH2210476.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award